EUVIMEDEUVIMED entdecken
Crossref

Development and Evaluation of Rosiglitazone-Loaded Floating Microspheres as a Gastroretentive Drug Delivery System

Dr. Dipali Talele, Dr. Neha Raghuwanshi, Shruti Moreshwar Thakre, Ms. Kavita Ramdas Mane, Dr. Prashant Kumar Singh, Mrs. Priyanka Mishra, Mohd Abdul Aali Khan, Ms. Sonika Prajapati

International Journal of Drug Delivery Technology · 16.04.2026 · 16 (13s)

DOI: 10.25258/ijddt.16.13s.15 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 16.04.2026. Verfasst von Dr. Dipali Talele und 7 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The present study was aimed at the development and evaluation of rosiglitazone-loaded floating microspheres as a gastroretentive drug delivery system to enhance gastric residence time and sustain drug release. Floating microspheres were prepared using the emulsion solvent diffusion–evaporation technique employing ethyl cellulose and hydroxypropyl methylcellulose (HPMC) as polymeric carriers. The prepared formulations were evaluated for percentage yield, particle size, entrapment efficiency, buoyancy, surface morphology, and in vitro drug release. The percentage yield of microspheres ranged from 72.4 ± 2.1% to 89.6 ± 1.8%, while particle size varied between 210 ± 12 µm and 385 ± 18 µm. Entrapment efficiency was found to be in the range of 68.3 ± 2.5% to 91.2 ± 1.6%. In vitro buoyancy studies indicated that the optimized formulation (F3) exhibited maximum buoyancy of 93.4 ± 1.7% and remained floating for more than 12 hours. Drug release studies demonstrated sustained release behavior with cumulative drug release of 94.5 ± 2.1% over 12 hours. Kinetic modeling revealed that the drug release followed the Higuchi model (R² = 0.987), indicating diffusioncontrolled release, while the Korsmeyer–Peppas model suggested non-Fickian diffusion (n = 0.74). Statistical analysis confirmed that formulation variables had a significant effect on all evaluated parameters (p < 0.05). The study concludes that rosiglitazone-loaded floating microspheres represent a promising gastroretentive system capable of enhancing drug bioavailability and providing sustained therapeutic action.

Zitieren

APA

Talele, D. D., Raghuwanshi, D. N., Thakre, S. M., Mane, M. K. R., Singh, D. P. K., Mishra, M. P., Khan, M. A. A., & Prajapati, M. S. (2026). Development and Evaluation of Rosiglitazone-Loaded Floating Microspheres as a Gastroretentive Drug Delivery System. International Journal of Drug Delivery Technology, 16(13s). https://doi.org/10.25258/ijddt.16.13s.15

Vancouver

Talele DD, Raghuwanshi DN, Thakre SM, Mane MKR, Singh DPK, Mishra MP, et al. Development and Evaluation of Rosiglitazone-Loaded Floating Microspheres as a Gastroretentive Drug Delivery System. International Journal of Drug Delivery Technology. 2026;16(13s). doi:10.25258/ijddt.16.13s.15

BibTeX
@article{Talele2026,
  author = {Talele, Dr. Dipali and Raghuwanshi, Dr. Neha and Thakre, Shruti Moreshwar and Mane, Ms. Kavita Ramdas and Singh, Dr. Prashant Kumar and Mishra, Mrs. Priyanka and Khan, Mohd Abdul Aali and Prajapati, Ms. Sonika},
  title = {Development and Evaluation of Rosiglitazone-Loaded Floating Microspheres as a Gastroretentive Drug Delivery System},
  journal = {International Journal of Drug Delivery Technology},
  year = {2026},
  volume = {16},
  number = {13s},
  doi = {10.25258/ijddt.16.13s.15}
}
Kostenlos starten →